Overcoming Resistance to Immune-Targeted Therapies

Fabrice Barlesi (Gustave Roussy, France)

Radial EBUS Guided TBLB for Peripheral Pulmonary Lesions

June Hong Ahn (Yeungnam Univ.)

ENB-Guided Preoperative Localization for Small Pulmonary Nodules

In Kyu Park (Seoul National Univ.)

ENB-Guided Ablative Therapy

Calvin S. H. NG (The Chinese Univ. of Hong Kong, Hong Kong)

A Prospective Phase 2 Study of Rapid Detection and EGFR-TKI Initiation by EV-Based BALF Liquid Biopsy in Advanced NSCLC Patients

In Ae Kim (Konkuk University)

Overall Survival with Afatinib as First-Line Therapy for Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in KATRD EGFR Cohort

Sung Yong Lee (Korea University )

Efficacy and Safety of Lazertinib 240 mg in Patients with EGFR T790M Mutant NSCLC: Data from a Phase I/II Study

Byoung Chul Cho (Yonsei University)

Sequential Afatinib and Osimertinib in Asians with EGFR Mutation-Positive NSCLC and T790M-Mediated Acquired Resistance: Combined Analysis of Two Non-Interventional Studies

Hyun Ae Jung (Sungkyunkwan University)

High Tumor Mutation Burden Predicts Unfavorable Clinical Outcomes in EGFR-Mutated Lung Adenocarcinoma Treated with Targeted Therapy

Seung Hyeun Lee (Kyung Hee University)

Combination Osimertinib Plus Selpercatinib for EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) with Acquired RET Fusions

Ari Jeon (Eli Lilly and Company)

Effect of N-acetylcysteine on Epithelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Patients

Jun Hyeok Lim (Inha University)

Efficacy and Safety of Selpercatinib (LOXO-292) in East-Asian Patients with RET Fusion-Positive NSCLC

Se Hoon Lee (Sungkyunkwan University)

Lorlatinib: Clinical Data and Implications for the Sequential Therapy in Anaplastic Lymphoma Kinase+Non-Small Cell Lung Cancer

Benjamin Solomon (Peter MacCallum Cancer Centre, Australia)

Phase II Prospective Study of Adjuvant Pembrolizumab in N2 Positive NSCLC Treated with Neoadjuvant CCRT Followed by Surgery

Sehhoon Park (Sungkyunkwan University)

Vision Artificial Intelligence Factor in Image Registration for Lung Stereotactic Body Radiotherapy

Kaile Li (Varian Medical System)

Phase 1 Trial Evaluating Safety of the Macrophage Target Sentinel Lymph Node Tracer (99mTc-MSA) Combined with Indocyanine Green for Intraoperative Sentinel Lymph Nodes Detection in Lung Cancer Surgery

Jun Hee Lee (Korea University)

Treatment Outcomes of Re-Irradiation Using Stereotactic Ablative Radiotherapy to Lung: A Propensity Score Matching Analysis

Tae Hoon Lee (Seoul National University)

Consolidative High-Dose Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer in Korea

Juwhan Choi (Korea University)

A Propensity-Matched Real-world Data Analysis of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

Cheol-Kyu Park (Chonnam National University )

Low-Level Expression of Necroptosis Factors Indicates a Poor Prognosis of the Squamous Cell Carcinoma Subtype of Non-Small-Cell Lung Cancer

Jun Hyeok Lim (Inha University )

Prognostic Significance of Extracapsular Extension in Patients with Pathologic N1 Non-Small Cell Lung Cancer Undergoing Complete Resection

Jae Kwang Yun (University of Ulsan)

Optimization of Indocyanine Green for Intraoperative Fluorescence Image-guided Thoracoscopic Resection of Lung Cancer

Yu Hua Quan (Korea University)

Radiotherapy for Resected Non-Small Cell Lung Cancer in Elderly Patients

Yoon Young Jo (University of Ulsan)

Is Moderate-Intensity Stereotactic Body Radiation Therapy Feasible for Ultra-Central Lung Cancer?: Updated Results

Chai Hong Rim (Korea University)

Predictive Biomarkers to Immune Checkpoint Blockade

Hye Ryun Kim (Yonsei Univ.)

Resistance Mechanisms to Immune Checkpoint Blockade

Se-Hoon Lee (Sungkyunkwan Univ.)

Novel Immune Checkpoint Blockade

Sehhoon Park (Sungkyunkwan Univ.)

Immunotherapy Beyond Immune Checkpoint Blockade

Ross Soo (National Univ. Cancer Institute, Singapore)

Shifting Paradigm in EGFRm Non-Small Cell Lung Cancer Treatment from Advanced to Early Stage Patients

Terufumi Kato (Kanagawa Cancer Center, Japan)

Lymphatic Pathways of the Thorax: Predictable Patterns of Spread of Non-Small Cell Lung Cancer

Jae Hyun Jeon (Seoul National Univ.)

MR Lymphangiography: Current Experiences Focusing on Lung Cancer

Hyun Jung Koo (Univ. of Ulsan)

Integrated LN Imaging for Lung Cancer Including CT, PET, and MRI: Update

Ho Yun Lee (Sungkyunkwan Univ.)

How to Handle Oligometastatic Disease in Non-Small Cell Lung Cancer

Hauke Winter (Universitätsklinikum Heidelberg, Germany)

Surgical Role in Oligometastasis to the Spines

Seung-Jae Hyun (Seoul National Univ.)

Local Ablative Therapy with Radiation in Extra-Thoracic Visceral Oligometastasis

Jin Ho Kim (Seoul National Univ.)

A New Era in the Treatment of EGFR Mutation: LECLAZA®

Jin Hyoung Kang (The Catholic Univ. of Korea )

Oligometastasis with Radiotherapy and Immunotherapy

To Be Confirmed

Integrating Metabolism with Systems Immunology in Immunity and Cancer

Hongbo Chi (St. Jude Children's Research Hospital, USA)

Cold to Hot Conversion

In-San Kim (KIST)

How Can We Enhance the Treatment Responses of Anti-PD-1 in Cancers?

Su-Hyung Park (KAIST)

Organoid Models for Lung Cancer Research

Se JIn Jang (Univ. of Ulsan)

Identification and Validation of Effective Cancer Neoantigens

Jung Kyoon Choi (KAIST)

Interpatient and Intratumor Heterogeneity of Drug Distribution

Maurizio D'Incalci (Humanitas Research Hospital, Italy)